Abiopharma

🔍 ROTHBLATT MARTINE A (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2026-05-11

Detailed Transactions and Holdings:

• Acquired 9,500 shares of Common Stock at $146.03 per share (Direct)
  Date: 2026-05-11 | Code: M | equity_swap_involved: false | shares_owned_after: 50,013.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,165 shares of Common Stock at $569.501 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: false | shares_owned_after: 48,848.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 2,019 shares of Common Stock at $570.2082 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: false | shares_owned_after: 46,829.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 1,356 shares of Common Stock at $571.4255 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: false | shares_owned_after: 45,473.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 1,292 shares of Common Stock at $572.3861 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: false | shares_owned_after: 44,181.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 397 shares of Common Stock at $573.1755 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: false | shares_owned_after: 43,784.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 578 shares of Common Stock at $574.3757 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: false | shares_owned_after: 43,206.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 658 shares of Common Stock at $575.3262 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: false | shares_owned_after: 42,548.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 210 shares of Common Stock at $576.9254 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: false | shares_owned_after: 42,338.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 964 shares of Common Stock at $577.7985 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: false | shares_owned_after: 41,374.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Sold 227 shares of Common Stock at $578.7307 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: false | shares_owned_after: 41,147.00 | transaction_form_type: 4 | Footnotes: F1, F11
• Sold 514 shares of Common Stock at $579.8461 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: false | shares_owned_after: 40,633.00 | transaction_form_type: 4 | Footnotes: F1, F12
• Sold 120 shares of Common Stock at $580.4433 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: false | shares_owned_after: 40,513.00 | transaction_form_type: 4 | Footnotes: F1, F13
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-11 | Code: H | nature_of_ownership: by Spouse | shares_owned_after: 166.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-11 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 324,443.00 | Footnotes: F14
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-11 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 258,117.00 | Footnotes: F15
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-11 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 45,596.00 | Footnotes: F16
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-11 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 10,962.00 | Footnotes: F17
• Sold 9,500 shares of Stock Option at $146.03 per share (Derivative)
  Date: 2026-05-11 | Code: M | Expires: 2027-03-15 | Exercise: 2020-03-15 | equity_swap_involved: false | shares_owned_after: 15,288.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026.
• F10: This transaction was executed in multiple trades at prices ranging from $577.32 to $578.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F11: This transaction was executed in multiple trades at prices ranging from $578.35 to $579.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F12: This transaction was executed in multiple trades at prices ranging from $579.41 to $580.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F13: This transaction was executed in multiple trades at prices ranging from $580.44 to $580.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F14: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F15: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F16: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F17: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F2: This transaction was executed in multiple trades at prices ranging from $568.89 to $569.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F3: This transaction was executed in multiple trades at prices ranging from $569.89 to $570.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $570.89 to $571.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $571.90 to $572.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $572.92 to $573.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $573.92 to $574.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $574.95 to $575.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: This transaction was executed in multiple trades at prices ranging from $576.32 to $577.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.